Results for the substance andexanet alfa

Andexanet alfa is a medication used as an antidote to reverse the effects of direct oral anticoagulants that inhibit factor Xa, such as apixaban and rivaroxaban. It is indicated in cases of severe or life-threatening bleeding caused by the use of these anticoagulants.

Andexanet alfa works by directly binding to factor Xa inhibitors, neutralizing their effects and restoring normal blood clotting. It is administered intravenously, usually as an infusion, with the dosage adjusted based on the type and dose of the anticoagulant used.

Common side effects include injection site reactions, upper respiratory tract infections, and flu-like symptoms. In rare cases, severe adverse reactions such as thrombotic events or allergic reactions may occur.

Patients receiving andexanet alfa should be closely monitored for signs of excessive clotting or other adverse reactions. The use of this medication must be strictly supervised by a specialist, as restoring coagulation can increase the risk of thrombosis. Andexanet alfa is a life-saving option for managing severe bleeding associated with factor Xa anticoagulants.